|
Block h6: imdrf device code a010402 captures the reportable event of stent migration.Imdrf patient code e2114 captures the reportable event of perforation.Block h11: investigation results: based on the available information, boston scientific could not confirm the reported event of stent migration and perforation.The device was not returned for analysis as it remains implanted; therefore, a technical analysis could not be performed.However, stent migration and perforation is noted within the instructions for use (ifu) as a possible adverse event associated with the use of the device.Device history record review: it was confirmed this device met manufacturing specifications prior to distribution and there were no manufacturing deviations which could have contributed to the reported event.Device technical analysis: the device was not returned for analysis as it remains implanted; therefore, a technical analysis could not be performed.Risk review: a risk review of the advanix biliary stents was completed and confirmed that the events of stent migration and perforation were defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Labeling review: a labeling review was performed and, from the information available, there is no information that this device was used in a manner inconsistent with the instructions for use (ifu)/ product label.Additionally, stent migration and perforation are noted within the instructions for use (ifu) as a known possible adverse event related to the use of the device.Investigation conclusion: based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.
|
|
Note: this report pertains to one of two advanix biliary stents with naviflex delivery systems used in the same patient.Refer to complaint id (b)(4) for the associated device information.It was reported to boston scientific corporation that two advanix biliary stents with naviflex delivery systems were implanted transduodenally to treat a suspected cholangiocarcinoma during an endoscopic retrograde cholangiopancreatography (ercp) procedure performed on (b)(6) 2026.The advanix biliary stents were correctly implanted.However, on (b)(6) 2026, the patient presented to the emergency room; yet no symptoms were reported.On (b)(6) 2026, the patient underwent a computed tomography scan (ct), which revealed a perforated duodenum.Imaging also indicated that the stents had migrated distally from the intended implantation site.The patient was subsequently hospitalized and underwent surgery to repair the duodenal perforation.The stents were not explanted as a result of this adverse event and will remain in place until a scheduled explant procedure on (b)(6) 2026.
|